Patna, Ta. Tuesday 14 July 2020
Human trial of India-made vaccine has started. The Indian vaccine is called covexin. 10-11 days ago, the government said that vaccine testing would be started very soon and in major institutions of the country. Under which testing of vaccine has been started in AIIMS Patna.
18 volunteers have been selected for this. The essence of what is stated in a news website is that many vaccines have been tested in the world. These include Morden, Cancino, Innovio, Bioentech, Pfizer and Estrogenaca vaccines. At AIIMS Patna, 18 people have been selected for human testing of the vaccine.
For which a period of 6 months has been selected. Institutions in which human trial of this vaccine will be done include AIIMS in New Delhi and Patna, PGI Rohtak, Gorakhpur Rana Hospital, Prakhar Hospital in Kanpur, Gilukar Multispeciality Hospital in Nagpur, Rodhekar Hospital in Goa, SUM Hospital in Odisha. George Hospital, Jeevan Rekha Hospital in Belgaum, Karnataka, SRM Hospital in Chennai, NIMS Hospital in Hyderabad.
The ICMR said that out of the 18 people selected for the vaccine test, the first to be vaccinated would be those who are physically and mentally ready. Covexin is manufactured by Bharat Biotech Company, Hyderabad.
The vaccine will be given to people aged 18 to 55 in the first phase and to people aged 12 to 65 in the second phase. For which 375 to 750 people will be tested. All health tests will be performed on the person who submits the consent letter first in the 28-day process. It will then be tested.
Comments
Post a Comment
What you think about this NEWS please post your valuable comments on this article, we will immediately publish your comments on this page